drug discovery

News

Alphabet's DeepMind forms AI drug discovery unit Isomorphic ...

Google parent Alphabet has drawn on its DeepMind artificial intelligence division to form a drug discovery unit that it calls Isomorphic Labs.

News

AI specialist Exscientia raises $510m in upsized IPO, placin...

Exscientia's artificial intelligence-based drug discovery engine is still largely unproven, but that hasn't stopped the company raking in funding from investors keen to back its platform.

Events

Partner Content

3rd Inflammasome Therapeutics Summit

Targeting the Inflammasome

News

Lundbeck taps Inscopix' brain-mapping camera tech for CNS re...

Danish drugmaker Lundbeck has teamed up with Inscopix – the developer of a technology that can film neurons in the brain in real time – to try to find new drugs for central nervous system d

News

BMS buys into AI-designed immune drug from Exscientia

Bristol Myers Squibb has exercised an option on an immune-modulating drug candidate developed by UK artificial intelligence specialist Exscientia, paying $20 million for the buy-in as part

News

AI firm XtalPi swells its coffers with another $400m financi...

Artificial intelligence (AI) specialist XtalPi has chalked up a second big financing in the space of a year, raising $400 million and taking its valuation to around $2 billion.

Alphabet's DeepMind forms AI drug discovery unit Isomorphic ...

AI specialist Exscientia raises $510m in upsized IPO, placin...

3rd Inflammasome Therapeutics Summit

Lundbeck taps Inscopix' brain-mapping camera tech for CNS re...

BMS buys into AI-designed immune drug from Exscientia

AI firm XtalPi swells its coffers with another $400m financi...

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

drug discovery

Editor's Picks